Howard University Hospital

Washington D.C., District of Columbia 20060'

2 studies enrolling now · 59 studies all time

What they study most

Active Cutaneous Lupus Erythematosus, Acute Chest Syndrome, Adenocarcinoma of the Colon, Adolescent Pregnancy, Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Inv(16)(p13;q22), Adult Acute Myeloid Leukemia With t(15;17)(q22;q12), Adult Acute Myeloid Leukemia With t(16;16)(p13;q22), Adult Acute Myeloid Leukemia With t(8;21)(q22;q22), Anemia, Sickle Cell, Arthritis, Rheumatoid, Atrial Fibrillation

Studies at this site

• BRAVE Program to Improve Safety and Reduce Violence Risk in Early Psychosis — Recruiting now
• Polygenic Risk Stratification Combined With mpMRI to Identify Clinically Relevant Prostate Cancer — Recruiting now
• Spironolactone Initiation Registry Randomized Interventional Trial in Heart Failure With Preserved Ejection Fraction — Recruiting now
• Clinical Trial of Solanezumab for Older Individuals Who May be at Risk for Memory Loss — Completed
• Secondary Pulmonary Hypertension in Adults With Sickle Cell Anemia — Completed
• Sunitinib Malate as Maintenance Therapy in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer Previously Treated With Combination Chemotherapy — Completed
• Comparison of Combination Chemotherapy Regimens With or Without Cetuximab in Treating Patients Who Have Undergone Surgery For Stage III Colon Cancer — Completed
• Doxorubicin Hydrochloride, Cyclophosphamide, and Paclitaxel With or Without Bevacizumab in Treating Patients With Lymph Node-Positive or High-Risk, Lymph Node-Negative Breast Cancer — Running, not enrolling
• Oxaliplatin, Leucovorin, and Fluorouracil With or Without Bevacizumab in Treating Patients Who Have Undergone Surgery for Stage II Colon Cancer — Running, not enrolling
• RECOVER-SLEEP: Platform Protocol — Completed
• RECOVER-VITAL: Platform Protocol to Measure the Effects of Antiviral Therapies on Long COVID Symptoms — Completed
• Phase 2a Study of VX-147 in Adults With APOL1-mediated Focal Segmental Glomerulosclerosis — Completed
• Functional Assessment and Muscle Evaluation Through Exercise Trial — Completed
• Efficacy and Safety of Rivipansel (GMI-1070) in the Treatment of Vaso-Occlusive Crisis in Hospitalized Subjects With Sickle Cell Disease — Completed
• The Provider Awareness and Cultural Dexterity Toolkit for Surgeons Trial — Completed
• Study to Evaluate BIIB059 (Litifilimab) in Cutaneous Lupus Erythematosus (CLE) With or Without Systemic Lupus Erythematosus (SLE) — Completed
• Dissemination and Implementation of Stroke Prevention Looking at the Care Environment — Completed
• Cocaine Use Reduction With Buprenorphine — Completed
• Hypnosis to Manage Pain and Symptoms in Patients With Sickle Cell Disease — Completed
• Longitudinal Pediatric Palliative Care: Quality of Life & Spiritual Struggle — Completed
• Safety Study Of Tofacitinib Versus Tumor Necrosis Factor (TNF) Inhibitor In Subjects With Rheumatoid Arthritis — Completed
• GLORIA-AF Registry Program - Second and Third Phases — Completed
• Saffron as Anti Inflammatory Agent In Patients With Inflammatory Bowel Disease — Status unconfirmed
• Safety of Rivipansel (GMI-1070) in the Treatment of One or More Vaso-Occlusive Crises in Hospitalized Subjects With Sickle Cell Disease — Stopped early
• Niacin to Improve Blood Flow in People With Sickle Cell Disease — Completed
• Study to Assess Changes in the Immune Profile in Adults With Early Rheumatoid Arthritis — Completed
• Tele-HF: Yale Heart Failure Telemonitoring Study — Completed
• Genetic Analysis of Hereditary Prostate Cancer — Completed
• Nitric Oxide Inhalation to Treat Sickle Cell Pain Crises — Completed
• Pulmonary Hypertension, Hypoxia and Sickle Cell Disease — Completed
• A Study of Prasugrel in Pediatric Participants With Sickle Cell Disease (SCD) — Stopped early
• Positive Imaging Study for Distant Metastases in Patients With Castration-Resistant Prostate Cancer — Stopped early
• Observational Study of the Use of Pegloticase (KRYSTEXXA®) in Refractory Chronic Gout — Completed
• A Study Of Inotuzumab Ozogamicin Plus Rituximab For Relapsed/Refractory Aggressive Non-Hodgkin Lymphoma Patients Who Are Not Candidates For Intensive High-Dose Chemotherapy — Stopped early
• Musculoskeletal Ultrasound in Asymptomatic Hyperuricemia — Status unconfirmed
• Safety of ICL670 vs. Deferoxamine in Sickle Cell Disease Patients With Iron Overload Due to Blood Transfusions — Completed
• AZD2171 in Treating Patients With Neurofibromatosis Type 1 and Plexiform Neurofibroma and/or Neurofibroma Near the Spine — Stopped early
• Safety, Pharmacokinetics (PK), and Efficacy of Buprenorphine Transdermal System (BTDS) in Children — Completed
• Choosing Healthful Interventions — Completed
• Examination of Tamoxifen in Acute Mania in Patients With Bipolar I Disorder — Completed
• Building Futures for Youth - Phase III — Completed
• SYMPLICITY HTN-3 Renal Denervation in Patients With Uncontrolled Hypertension — Completed
• Cediranib Maleate in Treating Patients With Relapsed, Refractory, or Untreated Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome — Completed
• Sildenafil Therapy for Pulmonary Hypertension and Sickle Cell Disease — Stopped early
• Effects of HQK-1001 in Patients With Sickle Cell Disease — Stopped early
• Aldosterone Antagonist Therapy for Adults With Heart Failure and Preserved Systolic Function — Completed
• Adenosine 2A Agonist Lexiscan in Children and Adults With Sickle Cell Disease — Completed
• IMPACTS Trial: Investigation of the Modulation of Phospholipase in Acute Chest Syndrome — Completed
• Acute Stroke Program of Interventions Addressing Racial and Ethnic Disparities — Completed
• Oblimersen in Treating Patients With Relapsed or Refractory Waldenstrom's Macroglobulinemia — Completed